Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release tablets for severe pain in bladder pain syndrome
2009-018118-21Phase 2Completed
- Sponsor
- Mundipharma Research
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone and naloxone in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Mundipharma Research. Primary endpoint: Pain Intensity Scale - average pain over the last 24 hours. Started May 2010; status: completed.
02
Drugs
oxycodonenaloxone
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2009-018118-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018118-21.